Conventional Karyotyping and Fluorescence In Situ Hybridization | Zendy

Rong He | Zendy; Anne E. Wiktor | Zendy; Curtis A. Hanson | Zendy; Rhett P. Ketterling | Zendy; Paul J. Kurtin | Zendy; Daniel L. Van Dyke | Zendy; Mark R. Litzow | Zendy; Matthew H. Howard | Zendy; Kaaren K. Reichard | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Conventional Karyotyping and Fluorescence In Situ Hybridization

Author(s) -

Rong He,

Anne E. Wiktor,

Curtis A. Hanson,

Rhett P. Ketterling,

Paul J. Kurtin,

Daniel L. Van Dyke,

Mark R. Litzow,

Matthew H. Howard,

Kaaren K. Reichard

Publication year - 2015

Publication title -

american journal of clinical pathology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.859

H-Index - 128

eISSN - 1943-7722

pISSN - 0002-9173

DOI - 10.1309/ajcpp6lvmqg4lnck

Subject(s) - karyotype , fluorescence in situ hybridization , biology , concordance , cytogenetics , chromosome , fish <actinopterygii> , genetics , fishery , gene

Cytogenetics defines disease entities and predicts prognosis in acute myeloid leukemia (AML). Conventional karyotyping provides a comprehensive view of the genome, while fluorescence in situ hybridization (FISH) detects targeted abnormalities. The aim of this study was to compare the utility of karyotyping and FISH in adult AML.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research